← Open Payments lookup

BRIDGET CRAIN: Open Payments

NPI 1033660113 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,607 in 121 payments from 22 companies in 2025. Trend: 2023 $1,977 · 2024 $2,500 · 2025 $2,607

Food & beverage: $2,607
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP22$495
GlaxoSmithKline, LLC.17$369
Amgen Inc.15$225
Grifols USA, LLC8$212
Boehringer Ingelheim Pharmaceuticals, Inc.9$207
Mallinckrodt Hospital Products Inc.9$191
Takeda Pharmaceuticals U.S.A., Inc.6$152
GENZYME CORPORATION6$127
Merck Sharp & Dohme LLC5$99
Viatris Specialty LLC4$81

Products named: TEZSPIRE, Prolastin-C Liquid, TRELEGY ELLIPTA, FASENRA, ACTHAR, DUPIXENT, NUCALA, OFEV.

Industry payments across AL — which companies pay providers there.